Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000540476 | SCV000633551 | likely benign | Familial cancer of breast; Fanconi anemia complementation group J | 2023-07-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000570764 | SCV000666264 | likely benign | Hereditary cancer-predisposing syndrome | 2017-06-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000570764 | SCV001349804 | likely benign | Hereditary cancer-predisposing syndrome | 2018-11-01 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004787863 | SCV005407051 | benign | Familial cancer of breast | 2024-08-27 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |